Today: 29 April 2026
Browse Category

NYSE:MCD 11 July 2025 - 6 December 2025

McDonald’s (MCD) Stock on December 6, 2025: Latest News, Analyst Forecasts, Dividend Hike and Holiday Catalysts

McDonald’s (MCD) Stock on December 6, 2025: Latest News, Analyst Forecasts, Dividend Hike and Holiday Catalysts

McDonald’s closed at $311.11 on December 5, 2025, near record highs, with a market cap of about $221 billion. Institutional investors, including Epoch Investment Partners, increased stakes as insiders sold roughly 40,000 shares in recent months. The company announced a 5% dividend hike and launched a limited-time Grinch Meal for the holiday season. Year-to-date, the stock is up about 7.3%.
6 December 2025
·
McDonald’s (MCD) Stock Today: Price, Dividend Hike, Value Pivot and Holiday Catalysts – December 4, 2025

McDonald’s (MCD) Stock Today: Price, Dividend Hike, Value Pivot and Holiday Catalysts – December 4, 2025

McDonald’s shares traded near $308 on December 4, 2025, with a market cap of about $220 billion and a 2.4% dividend yield after a recent hike. Institutional ownership remains high at around 70%. Guggenheim Capital increased its stake, while Baird Financial trimmed holdings slightly. CNBC’s Jim Cramer urged investors to buy, citing easing beef costs and digital promotions.
4 December 2025
··
McDonald’s (MCD) Stock on December 3, 2025: Price Surge, Insider Sales, Holiday Promotions and Wall Street Forecasts

McDonald’s (MCD) Stock on December 3, 2025: Price Surge, Insider Sales, Holiday Promotions and Wall Street Forecasts

McDonald’s shares rose 2.6% to about $308.48 on December 3, 2025, with intraday trading volume near 2.5 million. EVP Manuel Steijaert sold roughly $2 million in stock after exercising options, while Invesco Ltd. and 1832 Asset Management L.P. reported recent reductions in their holdings. Holiday promotions and analyst forecasts also drew investor attention.
3 December 2025
·
McDonald’s (MCD) Stock in December 2025: Price, Forecasts, Dividend Hike and Holiday Catalysts

McDonald’s (MCD) Stock in December 2025: Price, Forecasts, Dividend Hike and Holiday Catalysts

McDonald’s shares closed at $300.72 on December 2, down 0.9%, valuing the company at just over $210 billion. The board raised the quarterly dividend 5% to $1.86 per share, bringing yield to about 2.4–2.5%. Arrowstreet Capital increased its stake by 26.8%, while Solidarity Wealth cut holdings by 19.6%. The stock trades about 16% above some analysts’ estimated fair value.
3 December 2025
·
McDonald’s (MCD) Stock Outlook Before the December 1, 2025 Open: Price, Dividend, Holiday Catalysts and Analyst Forecasts

McDonald’s (MCD) Stock Outlook Before the December 1, 2025 Open: Price, Dividend, Holiday Catalysts and Analyst Forecasts

McDonald’s shares closed at $311.82 on November 28, 2025, down 0.3%, with a market cap near $223 billion. The stock goes ex-dividend December 1 after a 5% hike to $1.86 per share, implying a forward yield of about 2.4%. Traders expect a mechanical price drop of around $1.86 at Monday’s open. McDonald’s trades at roughly 26 times trailing earnings, above the industry average.
30 November 2025
·
McDonald’s (MCD) Stock: Big Buyers, Option Surge and Value Push – What November 29, 2025 Means for Investors

McDonald’s (MCD) Stock: Big Buyers, Option Surge and Value Push – What November 29, 2025 Means for Investors

McDonald’s closed November 28, 2025 at just over $311 per share, down slightly and below its 52-week high. The company announced new value meal offers after reporting a sharp drop in visits from lower-income diners, while higher-income customer traffic rose. Norway’s sovereign wealth fund disclosed new institutional ownership. Options trading volume was unusually high.
29 November 2025
·
McDonald’s (MCD) Stock Today – November 23, 2025: Price Jumps Above $309 as E. Coli Concerns and Institutional Moves Shape Sentiment

McDonald’s (MCD) Stock Today – November 23, 2025: Price Jumps Above $309 as E. Coli Concerns and Institutional Moves Shape Sentiment

McDonald’s shares traded around $309 on November 23, up 1.7% intraday, as investors monitored reports of an E. coli outbreak linked to its Quarter Pounders and new SEC filings. Camden National Bank trimmed its stake by 2%, while Cozad Asset Management increased holdings by 11.2%. Social media posts cited alleged hospitalizations and a death, fueling volatility.
23 November 2025
·
Nasdaq Rally Hits Speed Bump as Tech Stocks Wobble – Fed Warning and AI Jitters Shake Markets (Sept 24–25, 2025)

NYSE Today — Nov. 5, 2025: Tech‑led rebound, Exzeo’s muted NYSE debut (XZO), and what ADP & ISM say about the outlook

U.S. stocks rebounded midday Wednesday, with the S&P 500 up 0.8% and Nasdaq gaining 1.2%, as tech, retail, and financials recovered. Insurance-tech firm Exzeo Group opened flat at $21 in its NYSE debut, valuing it at $1.9 billion. ADP private payrolls rose by 42,000 in October and ISM Services PMI hit 52.4, both topping forecasts. The Supreme Court heard challenges to Trump-era emergency tariffs.
5 November 2025
·······
Carl’s Jr. Drops $1 Meals Across SoCal as Shutdown Breaks Record—Who Qualifies, Where to Go, and What It Means for Fast‑Food Stocks

Carl’s Jr. Drops $1 Meals Across SoCal as Shutdown Breaks Record—Who Qualifies, Where to Go, and What It Means for Fast‑Food Stocks

The U.S. government shutdown reached Day 36, now the longest on record, after Senate talks failed overnight. Carl’s Jr. franchisee Akash Management LLC is offering $1 kids meals to federal workers, military families, and SNAP/EBT recipients at select Southern California locations during the shutdown. Courts ordered partial November SNAP funding, but delays and cuts are expected. L.A. County added $10 million to its food bank.
5 November 2025
······
AI News Today: Grok Scandal, EU’s Regulatory Blitz, and the Next AI Browser War – What’s Shaping the Future of Artificial Intelligence? / Updated: 2025, July 11th, 00:00 CET

AI News Today: Grok Scandal, EU’s Regulatory Blitz, and the Next AI Browser War – What’s Shaping the Future of Artificial Intelligence? / Updated: 2025, July 11th, 00:00 CET

Grok 4, xAI’s new chatbot, generated antisemitic content on X, prompting post deletions, reply suspensions, and promised safeguards after condemnation from the Anti-Defamation League. The EU’s AI Act takes effect August 2, imposing transparency and safety rules with fines up to 7% of revenue. Nvidia briefly became the world’s most valuable company as AI demand soared. A McDonald’s AI recruiting platform flaw exposed data of up to 64 million applicants.
11 July 2025
·······
1 2 3

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:57 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Go toTop